Agreed, the markets will resume their rise after they've
Agreed, the markets will resume their rise after they've forced the uninformed into margin calls and take their money. They'll also wipe out all the call options that will expire worthless so more money in "their" pockets!
The economic news is actually pretty decent and getting better like March retail sales. If they would put the clamps on the traders that run up oil and brought it back to say 70-75 bbl the economy would rock and so would stocks.
The financial markets are so riggggggged it's really quite pathetic and all we can do is try and go with the flow. I see you mentioned cnbc or maybe that's where the article you posted came from, they are the biggest financial avenue of news that reports nothing but bull$hit! The talking heads are all full of $hit like the self professed cheat Cramer.
They may have had good intentions when they first started but now it's just another tool for the crooks to get peoples hard earned money.
They'll say stukk like it's down on low volume, means nothing! Means nothing, I'm still down 10% whether it's low volume or high volume, can't believe they even make such a statement, idiots........!
Creative Edge Nutrition Inc. (FITX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Introducing the 7406 Incubator Shaker by Caron Scientific Caron Scientific, Inc. has raised the bar in environmental testing and laboratory equipment with the launch of their newest innovation: the 7406 Incubator Shaker. Known for its dedication to providing state-of-the-art incubation solutions, Caron Scientific presented this remarkable product at a prominent...
Continue Reading
US Stocks Look to Rebound Following Recent Sell-Off U.S. stock futures showed an upward trend recently, bouncing back from a notable sell-off. Most benchmark indices are witnessing gains in premarket trading while the small-cap Russell 2000 remains slightly down. Nvidia's Effects on Technology Sector Nvidia Corp. (NASDAQ: NVDA) experienced a significant decline of over 8%...
Continue Reading
Understanding the Avantor, Inc. Class Action Lawsuit Avantor, Inc. (NYSE: AVTR) is a prominent provider of scientific products and services designed to cater to various sectors including biotechnology and pharmaceuticals. This article sheds light on the ongoing class action lawsuit initiated on behalf of investors who acquired shares of Avantor during a specified class...
Continue Reading
Hyphens Pharma Collaborates with Louis Widmer for Cerapro® MED Hyphens Pharma International Limited is thrilled to announce a significant partnership with Louis Widmer SA for the commercialization of their innovative product, Cerapro® MED Skin Barrier Cream. This agreement enables Louis Widmer to promote and distribute Cerapro® MED in six European countries. About...
Continue Reading
Engagement in a Notable Investor Conference Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has exciting news for its stakeholders! The company recently declared its participation in an essential fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference. This event is set to take place in Boston and will commence at 11:30 a.m. PT / 2:30 p.m. ET on a Tuesday...
Continue Reading